The Horsemen's Benevolent and Protective Association of Ontario
Addendum to the CPMA 2016 Elimination Guidelines Booklet
The Canadian Pari-Mutuel Agency (CPMA) is pleased to provide the Canadian horse racing industry with the following new elimination guidelines. The information published in the 2016 Elimination Guidelines book continues to be valid. There is no date for publication of a new edition of the book.
Dosage Regimen and Elimination Guideline (EG)
|4||Cetirizine1||Reactine||200 mg PO||Single||72 hours|
|5||Clodronate2||Osphos||720 mg IM||Single||30 days|
|4||Dexamethasone||Dexamethasone 5||20 mg IM||Single||48 hours|
|5||Fluticasone||Flovent||2 mg AER||Twice daily for 7 days||24 hours|
|5||Triamcinolone acetonide||Viaderm KC||10 mg TOP||Single||24 hours|
1 Note that concurrent administration of cetirizine and oral ivermectin will significantly increase the elimination time of cetirizine.
2 Applies to horses 4 years of age and older. For more details, see CPMA Industry Notification dated May 31, 2018, “Addition of clodronate and tiludronate to the Schedule of Prohibited Drugs in the Pari-Mutuel Betting Supervision Regulations.”
PO Per os (oral)
It is stressed that these results are presented as guidelines only and should not be construed as absolute for every horse to which this drug is administered.
The guidelines in this notice should not be applied to a compounded product and may not be consistent with foreign regulations and laboratory methods.
As always, the CPMA strongly recommends that your veterinarian be consulted on any decision to administer any supplement or product to a horse.
Should you have any questions or concerns regarding this matter, please do not hesitate to contact CPMA at email@example.com or by calling 1-800-268-8835.